About.com taps WebMD for health exec

Share this article:
About.com upped the ante on its health offering, bringing on Marjorie Martin from archrival WebMD to head About Health (health.about.com). 

Martin, who started out as a TV news correspondent and spent eight years at WebMD, most recently as VP and managing director, is charged with adding features and plotting strategy to expand and differentiate the site. She reports to COO Andrew Pancer. 

With 4.9 million unique visitors in March, according to Nielsen Net Ratings, About Health lags behind WebMD (22.6 million) and MSN Health (5.7 million), but leads both AOL Health (4 million) and Yahoo! Health (2.8 million). 

About.com president and CEO Scott Meyer said the site is the strongest of the About.com properties, recently bought by The New York Times Company, and that the firm sought to leverage its expertise and original content to pull ahead of the portals.

“What we really have is two sites [About and WebMD] publishing quality original content, and the portals are really just aggregating content from elsewhere,” said Meyer. About Health, he said, projects the “voice of reason,” with credentialed expert guides trained by the company and paid based on the traffic their sites generate. 

Meyer said the sector had seen sharp growth in online advertising spending recently, from pharmas as well as from device manufacturers and consumer packaged-goods companies.
Share this article:
close

Next Article in News

Email Newsletters

More in News

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.

Amgen Q2 sales rise, company to lay off up to 2,900

Amgen Q2 sales rise, company to lay off ...

The majority of the layoffs will be in the US.

Doctors want to know how CMS plans to display Sunshine payment data

Doctors want to know how CMS plans to ...

Physician and industry trade groups are asking CMS to explain how context will be provided to the general public around the dollar sums drugmakers ascribe to doctors for things like ...